{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:53:36Z","timestamp":1778885616288,"version":"3.51.4"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMM"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>In order to combat the vast array of infectious agents it may encounter, the\nadaptive immune system develops a tremendously diversified antibody repertoire. B\ncells expressing polyreactive or autoreactive antibodies are eliminated through multiple\ncheckpoints during early B cell development. Defects in any of these checkpoints may\nlead to the production of polyreactive or autoreactive antibodies, and cause autoimmune\ndiseases. However, recent studies on a panel of established HIV-1-neutralizing\nantibodies and a large collection of recombinant anti-gp160 antibodies derived from HIV-\n1-infected individuals showed that many of these antibodies are polyreactive or\nautoreactive. Whether these antibodies play important roles in combating HIV-1 infection\nor if they are merely by-products of chronic HIV-1 infection remains to be determined. In\nthis review, we discuss the abnormalities in adaptive immune responses against HIV-1\ninfection with a focus on neutralizing antibodies against different antigenic epitopes of\nHIV-1 proteins. We also provide insight into the functional attributes of polyreactivity and\nautoreactivity as common and conserved features of HIV-1-specific antibodies.\nFurthermore, we summarize the autoantibodies isolated from HIV-infected individuals\nand their associations with clinical autoimmune diseases. Finally, we consider the\nopportunities and drawbacks of utilizing polyreactive antibodies from HIV-infected\nindividuals to guide strategies aimed at developing effective antibody-based vaccine and\ntherapeutic interventions for HIV. Understanding how polyreactive and autoreactive anti-\nHIV-1 antibodies are generated during the course of HIV-1 infection may provide new\ninsights that will inform future vaccine design.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1566524018666180720165406","type":"journal-article","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T07:39:37Z","timestamp":1532331577000},"page":"126-133","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Polyreactive Antibodies in Anti-HIV-1 Responses"],"prefix":"10.2174","volume":"18","author":[{"given":"H.","family":"Liao","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041,China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, West China Second University Hospital, State Key Laboratory of Biotherapy, Ministry of Education Key Laboratory of Birth Defects, Sichuan University, Chengdu, Sichuan, 610041,China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1566524018666180720165406","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/163960\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1566524018666180720165406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:23:48Z","timestamp":1761665028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/163960\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1566524018666180720165406","relation":{},"ISSN":["1566-5240"],"issn-type":[{"value":"1566-5240","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-04-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}